Direct link to this page: http://www.hta.ac.uk/1190

Details of HTA journal title

Last updated: 12 November 2008 - Next update due: 18 November 2008

Research type:

NICE Technology Assessment Report (TAR) 

Title (lead author) etc:

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease  (Clegg) 137 pages, Volume 5, number 1

Link to NICE guidance page

DOI

10.3310/hta5010
|  View/print executive summary
|  View/print minisummary in rtf format
|  View full text in pdf format (615 KB)

| Buy a printed version of this title - cost £20.00 each. [How to order]
# This title is available on our CD-ROM of the journal.
| Order a CD-ROM - free of charge worldwide.  
Outputs in journals arising from this project

Project ref:

00/08/01 

Original project title:

The clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease 

Chief Investigator:

Southampton Health Technology Assessment Centre (SHTAC), University of Southampton  

Start Date:

May 2000.  

Publication date:

March 2001

Cost:

 This project was commissioned by the HTA programme on behalf of the National Institute for Health and Clinical Excellence on a call-off contract basis

MeSH* index primary terms:

ALZHEIMER-DISEASE Q-drug-therapy; DONEPEZIL Q-therapeutic-use; RIVASTIGMINE Q-therapeutic-use (* = Medical Subject Headings)

MeSH* index secondary terms:

HUMAN; COST-BENEFIT-ANALYSIS  (* = Medical Subject Headings)

NRR* number, if applicable:

N0484078124 (*National Research Register) 

Project Protocol:

Project protocol not available

Printed copies of this title despatched:

342 (Figures relate to the previous calendar month)

Downloads/Views of electronic version from website:

45374 (Figures are cumulative.) Last updated 15th October 2008.

URL of this page:

http://www.hta.ac.uk/1190

Outputs from this project

  • Clegg, A; Bryant, J; Nicholson, T; McIntyre, L; De, Broe S; Gerard, K; Waugh, N. Clinical and cost effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease.. International Journal of Technology Assessment in Health Care, 2002; 18 (3) 497-507.
Wed, 12 Nov 2008 14:55:50 +0000

Advanced search How to use the search function